NCT05583188 2024-07-19
VIGOR
Galvanize Therapeutics, Inc.
Phase 4 Terminated
Clinical Trials
6 trialsNCT02996214 2020-02-13
LIPUSU
Nanjing Luye Sike Pharmaceutical Co., Ltd.
Phase 4 Unknown
NCT02299765 2017-11-27
Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC
Sichuan University
Phase 4 Terminated
NCT02316327 2016-10-05
Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab
Fundacion Clinic per a la Recerca Biomédica
Phase 4 Completed
NCT02000531 2016-01-13
Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population
Hoffmann-La Roche
Phase 4 Completed
NCT01336192 2011-04-15
MAGICAL
Tongji University
Phase 4 Unknown